Esophagus Cancer Clinical Trials

114 clinical trials for Esophagus Cancer across international registries, including 26 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Multimodal Deep Learning for Predicting Treatment Response to Neoadjuvant Chemoimmunotherapy in Esophageal Cancer — RECRUITING
• Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer — RECRUITING · NA
• Proton Therapy for Esophageal Cancer — RECRUITING · NA
• The Efficacy and Safety of Fosrolapitant and Palonosetron Hydrochloride for Injection in Preventing Nausea and Vomiting Caused by Multi-cycle Immunotherapy and Chemotherapy in Patients With Esophageal Cancer and Lung Cancer — RECRUITING · PHASE2
• CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer — RECRUITING · PHASE1
• Mayo Clinic Upper Digestive Disease Survey — RECRUITING
• Retrospective Review of Esophageal Cancer at MSKCC — RECRUITING
• Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA — RECRUITING · PHASE2
• The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study — RECRUITING
• Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes — RECRUITING · NA
• Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer — RECRUITING · PHASE3
• Target-specific immunoPET Imaging of Digestive System Carcinoma — RECRUITING · NA
• A Trial of the Combination of Afatinib and Palbociclib in Previously Treated Advanced Esophageal Squamous Cell Carcinoma — RECRUITING · PHASE1
• Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer Patients — RECRUITING · NA
• Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer — RECRUITING · NA
• Neoadjuvant Comprehensive Treatment for Unresectable Esophageal Cancer — RECRUITING · PHASE2
• HER2 Status in Esophagogastric Adenocarcinoma and Its Associations With Patient's Clinicopathological Outcomes — RECRUITING
• Goal-directed Enteral Nutritional Perioperative Management — RECRUITING · NA
• Multicenter Cohort Study of ESD and Chemo-radiotherapy for High-risk Early-stage Esophageal Cancer — RECRUITING
• Functional Imaging to Identify Radiosensitive Esophageal Cancer - a Biomarker Validation Study — RECRUITING
• A Clinical Study of Non-curative Resection Plus Radiotherapy After Endoscopic ESD for Superficial Esophageal Squamous Cell Carcinoma — RECRUITING
• MRI and CT Simulation in the Evaluation of Tumor Response and Target Volume Definition for Esophageal or Esophagogastric Cancer Patients Undergoing Chemoradiotherapy — RECRUITING · NA
• Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors — RECRUITING · PHASE1
• Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors — RECRUITING · PHASE1
• Supercharged TRAM Evaluation in Cervical Esophagogastroplasty After Esophagectomy — RECRUITING · NA
• A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors — RECRUITING · PHASE1
• Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer — SUSPENDED · PHASE1
• Perioperative FLOT(D) With Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Esophageal Cancer — NOT_YET_RECRUITING · PHASE1
• Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Endoluminal Vacuum Therapy to Prevent Anastomotic Leakage After Esophagectomy Due to Esophageal Cancer — ACTIVE_NOT_RECRUITING
• Statewide Unified Network for Remote Intervention of Strength and Exercise — NOT_YET_RECRUITING · NA
• A Phase 1 First-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell Engager, in Patients With Solid Tumors — NOT_YET_RECRUITING · PHASE1
• Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors — COMPLETED · PHASE1
• Combination of Cadonilimab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-006) — ACTIVE_NOT_RECRUITING · PHASE2
• A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies — TERMINATED · PHASE1
• Proton Beam Therapy in the Treatment of Esophageal Cancer — ACTIVE_NOT_RECRUITING · NA
• Clinical Study on Noninvasive Evaluation of Ivonescimab Antibody Distribution and Expression in Esophageal Cancer Patients by 89Zr-AK112 PET Imaging — NOT_YET_RECRUITING
• Imaging and Blood-Based Biomarkers for the Evaluation of Early Signs of Myocardial Injury After Thoracic Radiation Therapy — ACTIVE_NOT_RECRUITING
• Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer — COMPLETED · PHASE2
• Enhanced Assistance During Radiotherapy for Unmet Essential Needs — COMPLETED · NA
• Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery — NOT_YET_RECRUITING · PHASE2
• Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies — COMPLETED · PHASE1
• Tislelizumab Combined With Chemotherapy for the Perioperative Treatment of Esophageal Squamous Carcinoma — NOT_YET_RECRUITING · PHASE2
• Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer — COMPLETED · PHASE2
• A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer — COMPLETED
• Tumor Antigen-sensitized DC Vaccine As an Adjuvant Therapy for Esophagus Cancer — COMPLETED · PHASE1
• Tislelizumab as Single-Agent Neoadjuvant Immunotherapy in Resectable Esophageal Squamous Cell Carcinoma — NOT_YET_RECRUITING · PHASE2
• The Registry of Oncology Outcomes Associated With Testing and Treatment — COMPLETED
• Oncometabolome and MALDI-MSI in Upper GI Carcinomas - Chemosensitivity in Esophageal Carcinoma — ACTIVE_NOT_RECRUITING
• Impact of Dose to Cardiac Substructures on Survival in Patients With Esophageal Cancer Treated With Radiotherapy or Chemoradiotherapy (SATIATION) — OTHER

Refine this search